Navigation Links
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
Date:5/9/2008

1,191,955

Other non-current liabilities 118,118 116,070

Total liabilities 1,478,995 1,530,554

SHAREHOLDERS' EQUITY 1,382,280 1,354,420

TOTAL LIABILITIES & SHAREHOLDERS'

EQUITY $2,861,275 $2,884,974

WARNER CHILCOTT LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(in thousands of U.S. dollars)

(Unaudited)

Quarter Ended

Mar-31-08 Mar 31-07

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income / (loss) $ 33,658 $ (4,502)

Adjustments to reconcile net

income / (loss) to net cash provided by

operating activities:

Depreciation 2,925 2,354

Amortization of intangible assets 52,613 57,553

Amortization of debt finance costs 1,559 3,193

Stock compensation expense 1,810 1,685

Changes in assets and liabilities:

(Increase) in accounts receivable,

prepaid and other assets (8,614) (9,791)

(Increase) in inventories (6,706) (2,553)

(Decrease)/increase in accounts payable,

accrued expenses & other current liab's (13,832) 9,705

(Decrease)/increase in income taxes and

other, net (66,095) 407

Net cash (used in) / provided by

operating activities $ (2,682) $ 58,051

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchase of intangible assets
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
2. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
6. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
7. Warner Chilcott Reports the Death of Its Director James Andress
8. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
9. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. QMed, Inc. Reports July Medicare SNP Enrollments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  Pfenex Inc. (NYSE MKT: PFNX), a ... high-value and difficult to manufacture proteins including biosimilar ... financial results for the second quarter ended June ... of our initial public offering, we have the ... candidates, derived from our proprietary protein expression platform," ...
(Date:8/29/2014)... circuits are based on electrons, but one of the ... circuits, i.e. circuits based on light (photons) instead of ... create a stream of single photons and control their ... of attempts to achieve this control, but now scientists ... a steady stream of photons emitted one at a ...
(Date:8/29/2014)... August 29, 2014 The global ... billion in 2019. It is expected to grow ... 2019, and was valued at $1.8 billion in ... Transparency Market Research. , For more information regarding ... . , The research report, titled “Companion Diagnostics ...
(Date:8/29/2014)... 29, 2014 According to a new market ... global orthobiologics market was valued at USD 3,754.6 million in ... 5,519.9million in 2019at a CAGR of 5.9% from 2013 to ... and above is afflicted by bone and joint disorders, and ... 2020. This has and will continue to increase the demand ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Breakthrough in light sources for new quantum technology 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3
(Date:8/29/2014)... surprising discoveries about the body,s initial responses to ... team found that specialized cells in the intestine ... invasion and are the source of gut inflammation ... , Though aimed at the presence of ... that provides a barrier to protect the body ...
(Date:8/29/2014)... (Aug. 29, 2014) Scientists at the Barshop Institute ... of Medicine at the UT Health Science Center at ... the tissues of the longest-lived rodent, the naked mole ... the cells of naked mole rats protects and alters ... damaged and obsolete proteins. , The factor also protects ...
(Date:8/29/2014)... recently, little has been known about what genetic changes ... of scientists, one of whom is a University of ... that genes controlling the development of the brain and ... The study was published Aug. 28 in Science ... is online at http://www.sciencemag.org/ ., The domestication of ...
Breaking Biology News(10 mins):The early cost of HIV 2Factor in naked mole rat's cells enhances protein integrity 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3
... Chemical Engineering Camilla Kao to describe a bacterium, ... of producing antibiotics, immunosuppressants and anti-cancer drugs that ... to inhibit other bacterial strains competing for resources. ... but the process of cultivating bacteria is slow ...
... predatory garter snakes and their newt quarry is turning ... molecular level, another battle rages. And in this second, ... Biologists at Indiana University Bloomington, Utah State University and ... Nature that a toxin produced by the rough skinned ...
... that human eggs may develop directly from cultured ovarian ... Oocytes derived from the culture of OSE cells developed ... development into an embryo. These findings, published today in ... important new strategies for use in in vitro fertilization ...
Cached Biology News:Chemical Engineer Kao Explores Antibiotic Synthesis With DNA Chips 2Chemical Engineer Kao Explores Antibiotic Synthesis With DNA Chips 3Chemical Engineer Kao Explores Antibiotic Synthesis With DNA Chips 4At the molecular level, the predator is the prey 2At the molecular level, the predator is the prey 3Human Eggs Can Develop From Ovarian Surface Cells In Vitro 2
... Protein Staining Solution stains proteins in ... (detection limit >= 8 ng of ... washing and destaining processes can be ... of gel (20 min), proteins can ...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
...
Mouse polyclonal antibody raised against a partial recombinant PREB. NCBI Entrez Gene ID = 10113...
Biology Products: